Here we describe the latest approaches in quantitative high accuracy mass spectrometrybased proteomics and their application to quantitative proteomics studies of the whole kidney and nephron subsegments, both in humans and in animal models. We compare these studies with similar studies performed on other organ substructures. We argue that the newest technologies used for preparation, processing and measurement of small amounts of starting material are finally enabling global and subsegment-specific quantitative measurement of protein levels in the kidney and other organs. These new technologies and approaches are making a decisive impact on our understanding of the (patho)physiological processes at the molecular level.
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Organs are complex structures that consist of multiple tissues with different levels of gene expression. To achieve a comprehensive coverage and accurate quantitation data, organs should ideally be separated into morphological and/or functional substructures prior to gene or protein expression analysis. However, due to complex morphology and elaborate isolation protocols, this was so far often difficult to achieve. Kidneys are organs where functional and morphological subdivision is especially important. Each subunit of the kidney, the nephron, itself consists of more than 10 subsegments with distinct morphological and functional characteristics. For a full understanding of kidney physiology, global gene and protein expression analyses have to be performed at the level of the nephron subsegments; however, such studies have so far been extremely rare.
Here we describe the latest approaches in quantitative high accuracy mass spectrometrybased proteomics and their application to quantitative proteomics studies of the whole kidney and nephron subsegments, both in humans and in animal models. We compare these studies with similar studies performed on other organ substructures. We argue that the newest technologies used for preparation, processing and measurement of small amounts of starting material are finally enabling global and subsegment-specific quantitative measurement of protein levels in the kidney and other organs. These new technologies and approaches are making a decisive impact on our understanding of the (patho)physiological processes at the molecular level.
Introduction
The kidneys are complex and morphologically heterogeneous organs consisting in humans of approximately one million nephrons. These nephrons produce urine by filtration of blood, reabsorption of water and substances, and parallel secretion of various metabolites and waste products. Several nephrons are drained into collecting ducts, the kidney pelvis, and ureters. The nephrons and collecting ducts can be subdivided into various segments based on functional and morphological criteria giving rise to at least 12 specific segments (glomerulus, S1, S2 and S3 segments of the proximal tubule, thin descending limb, thin ascending limb, This complexity has been examined in much detail on the morphological and functional level but much less on the molecular level. Doucet and colleagues have provided a first attempt to establish an overview over the transcripts expressed along the human nephron using SAGE technology and identified nearly 1000 transcripts 2 . However, in order to understand the function of the kidney, the mechanisms leading to kidney disease or to aid in the development of disease markers, a more detailed map of the mammalian kidney on the protein level is required.
This review will focus on three areas of active research: 1) new developments in proteome technology allowing detection and quantitation of proteins in very small samples, 2)
4 novel methods enriching specific organ structures and cells using mouse lines expressing fluorescent proteins under organ-or cell specific promoters, and 3) application of these new developments to the kidney. Here we will mainly cover aspects relating to proteomics of solid organ structures; excellent reviews have recently described the state-of-the-art and challenges of urine proteomics 3-5 .
Latest developments in MS-based proteomics
Modern, gel-free and mass spectrometry (MS)-based quantitative proteomics is making a decisive impact across all life sciences and it is increasingly used in molecular physiology and anatomy. Relatively straightforward experiments based on high accuracy MS and powerful bioinformatics tools are capable of reliably identifying and quantifying expression levels of several thousand proteins per experiment, approaching the depth of message-based (RNA) assays and reaching the analytical capacity to completely map the smaller proteomes, such as that of yeast 6 . Likewise, recent progress in biochemical separation and enrichment protocols make it possible to detect dynamics of posttranslational modification sites upon a treatment, providing a wealth of information on signal transduction mechanisms that cannot be otherwise studied by genomics or transcriptomics 7 . Yet, the chemical diversity of protein sequences and limited accessibility of proteins in some tissues or sub-cellular structures still make a comprehensive proteome analysis a challenging task. In this chapter we will discuss recent developments in four major areas of a typical proteomics workflow: quantitative proteomics -specifically stable isotope labeling of proteins in cells and tissues, sample preparation, mass spectrometry measurement and data processing ( Figure   2 ).
a. Tools for in-vivo quantitative proteomics
Proteomics has long depended on 2D gels to quantify relative expression levels of proteins in a perturbed biological system 8, 9 . While historically important, 2D gel approaches 
b. Sample preparation
The second cornerstone of a proteomics experiment is sample preparation, which, in the context of this review, we will divide into organ substructure isolation and protein extraction. The former requires optimized protocols that depend on the anatomy of the analyzed organ substructure, which may vary in size, shape and accessibility; the latter concerns general issues of sample preparation in proteomics, such as solubility of membrane proteins and compatibility of lysis media with downstream sample processing (e.g. enzymatic digestion and MS analysis).
i. Substructure isolation
Various approaches have been used over the past ten years to isolate specific cell populations or subcellular structures from the kidney for transcriptome or proteome analysis.
These approaches are often limited by either the low yield of material (i.e. using handdissection of specific nephron subsegments) or by the varying degree of enrichment of cells or structures contaminated with other subsegments (i.e. in the case of brush border membrane vesicles contamined with other membranes). A problem common to all isolation techniques is 7 the control of enrichment and purity of the respective preparations. In the case of nephron segments, purity of segments can be tested using PCR or immunoblotting for transcripts or proteins with a high specificity for different subsegments. Care needs to be taken to control for contamination with other segments or cell types and to establish segment or cell-specific markers. Even though several proteins and genes are widely used as segment specific markers (i.e. NCC for the distal tubule, NKCC2 for the thick ascending limb, AQP2 for the collecting duct), several markers are much less segment specific. A similar problem is often encountered in preparing subcellular fractions such as brush border or basolateral membranes. Hand dissection of nephron segments has been performed for transcriptome analysis of human and rodent nephron segments 2, [19] [20] [21] . It often requires the perfusion and incubation of the tissue with collagenases before dissection 22, 23 . This approach is clearly limited by the low yield and is very time-consuming. A major advantage of this approach is the high purity of preparations.
Faster isolation techniques with higher yields have been applied to proximal tubules 24 and inner medullary collecting ducts 25, 26 using Percoll gradients or preparing only tissue from the inner medulla with a rather homogenous segment and cell population. Here the risk of contamination with other segments or cell populations is much higher. Transgenic mouse models expressing EGFP or other fluorescent proteins under the control of cell or segmentspecific promoters have become available over the last few years such as mice expressing EGFP in intercalated cells driven by the promoter for the B1 H + -ATPase subunit 27 . Kidneys from these mice can be used to isolate large quantitities of nephron segments or cells after digestion of the organ using fluorescence-guided sorting of segments or cells (COPAS:
complex object parametric analyzer and sorter) 28 . The purity of these preparations depends on the sorting parameters, the restricted expression of the fluorescent protein and the degree of tissue digestion.
Subcellular fractions have also been prepared from different nephron segments. In the proximal tubule, apical brush border membranes were enriched from rat cortex using the 8 traditional magnesium precipitation technique 29, 30 . Usually enrichments of the apical brush border membrane are in the range of 7-15fold but they also contain luminal membranes from other nephron segments as well as contamination with basolateral membranes. This basolateral component is reflected by the fact that typical basolateral membrane proteins such as the Na,K-ATPase are found in the brush border membrane fraction 29 . Recently, Knepper and colleagues used a chemical approach to biotinylate basolateral membranes in vivo and after homogenization of the kidney basolateral isolated proteins with CaptAvidin-agarose beads 31 . Clearly, the combination of new transgenic animal models and chemical approaches will in future allow for purer preprations of specific protein fractions from distinct cells or segments at larger quantities.
ii. Protein extraction
Once an organ substructure has been isolated, it needs to be homogenized and lysed in a way that enables the highest possible retrieval of its proteome. Due to the chemical diversity and different localization of the proteins in a cell/tissue, this is not a trivial task. Ideally, proteins should be extracted from a tissue and solubilized in a buffer containing a potent denaturating agent and a detergent, digested in-solution, and the resulting peptide mixtures should be separated by at least two orthogonal separation methods prior to MS analysis.
However, efficient extraction of membrane proteins requires potent ionic detergents, such as SDS, which complicates downstream processing of the sample as it inhibits commonly used proteases and is not compatible with MS. This problem is usually addressed either by running 1D SDS-PAGE after tissue homogenization/lysis and subsequent in-gel protein digestion 32 ; or by using less potent non-ionic detergents, such as N-Octylglucoside, during homogenization/lysis. Both approaches, however, have lower yields of proteins -especially membrane proteins -compared to SDS-based lysis protocols. Recently, Wisniewski et al introduced a sample preparation method that combines the advantages of the 1D gel-based workflow (SDS compatibility) and in-solution digestion (higher peptide yields after protein digestion) 33 . The method, termed filter-aided sample preparation (FASP), involves tissue homogenization/lysis in an SDS-containing denaturating buffer, which is followed by extensive washing, buffer exchange and protein digestion on a microcentricon filter. After digestion, peptides are spun through the filter in an MS-compatible buffer, collected and, if desired, further separated. Due to straightforward sample processing, this method is applicable to low amounts of material, making it especially attractive for analyses of organ substructures and has already been applied in the analysis of the hippocampal membrane proteome 34 .
c. LC-MS measurement
After successful extraction, proteins are digested by a protease and the resulting peptide mixtures are mass-measured and fragmented in a mass spectrometer. Even if previously separated, tissue-derived protein mixtures are usually so complex that they give rise to thousands of peptides upon digestion. Since simultaneous ionization of such complex peptide mixtures would lead to a significant decrease of the measurement dynamic range, they are further separated by liquid chromatography (LC) prior to MS measurement. Current LC-MS setups involve the use of nano-HPLC columns (inner diameter 25-75 µm and flow rates 100-500 nl/min), usually packed with reverse-phase C 18 material. These columns are directly coupled to an electrospray ionization source to minimize dead volume that may result in peak broadening after separation 35 . Such chromatographic setup results in a high peak capacity and resolving power, which directly affects the efficiency of the electrospray ionization and therefore increases the sensitivity and dynamic range of LC-MS measurement. Alternatively, HPLC fractions may be spotted on a target plate, mixed with a matrix and ionized using MALDI ionization 36 . An interesting development in peptide separation prior to MS is the introduction of the REPLAY chromatography, which is suitable for analysis of extremely low 
Global proteomics and the kidney
Kidneys are vital organs that regulate and mediate different processes such as acidbase and electrolyte balance, body fluid osmolality, blood pressure, elimination of metabolic waste products and secretion of hormones [52] [53] [54] . Due to its importance in body homeostasis, the kidney has frequently been subject to global gene expression analyses and the level of transcriptome and proteome and mass spectrometry-based proteomics has been extensively used in renal research. Current applications of renal and urinary proteomics are mainly directed to renal physiology and pathophysiology, especially to the identification of biomarkers and therapeutic targets. Consequently, current proteomic studies of the kidney encompass both basic research and clinical studies involving various tissue samples (e.g. biopsies) and urine. They differ in scope, depth and technical platform used, ranging from e.g.
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ageing-related protein expression changes in a mouse kidney based on the 2D gel technology 55 , to the peptide-based (phospho)proteome analysis of isolated nephron segments or their in vitro cellular models using LC-MS/MS analysis 25, 26, 31, 43, 46 .
Early global kidney proteomics studies were based on 2D gels. Sarto et al. 56 detected more than 2000 protein spots on a single 2-D gel of the whole kidney tissue and identified 47
proteins. More recently, kidney physiology has also been addressed at the systems level;
Knepper and co-workers have shown how large-scale transcriptomic or proteomic data acquisition can be used in a specific area of molecular physiology, such as the regulation of the AQP2 water channel by the antidiuretic hormone vasopressin 57 . Modern techniques in protein mass spectrometry as well as "next-generation" nucleotide sequencing lead to rapid accumulation of data which in turn requires computational systems biology to study physiology at the molecular level. Similarly, proteogenomics is regarded as one of the most attractive approaches towards discovering biomarkers 58 .
Kidney function has also been analyzed indirectly, by comparing plasma proteome to urinary proteome to gain insights in the mechanisms of protein filtering. Lulu et al. identified 2611 proteins in plasma and 1522 in urine and compared them to available proteomic data, arriving at three groups of proteins that are handled in different ways by the kidney 59 .
Proteomic studies can also be complemented by metabolomics, which is being regarded as an extension of proteomic analysis, e.g. in the case of acute kidney injury or in KO mouse tissues 60,61 .
Segment-directed proteomics in the nephron/kidney
In order to better understand physiology and pathophysiology of different organs, it is necessary to direct the analysis toward their functional and morphological subunits, rather than to the whole tissue. This approach has an additional advantage in that it simplifies the extracted protein mixtures and therefore facilitates detection of low-abundant gene products.
Furthermore, it simplifies subsequent bioinformatics analysis, e.g. the prediction of functional pathways. As discussed above, the isolation of the nephron segments is still largely performed manually, which limits the number of segments that can be handled in a short time window after organ harvesting. So far, there are very few proteomics studies that investigated isolated nephron segments. Pisitkun et al. used LC-MS of peptides from in-gel digests to identify 704
proteins from the rat inner medullary collecting duct (IMCD) nephron segment and quantify changes in expression of 165 proteins in response to long-term vasopressin administration using chemical labeling with isotope-coded affinity tags (ICAT) 26 . Several studies were performed on the glomeruli which can be isolated to relatively high purity by a standard sieving method from the human 62, 63 and animal 64 kidney and used in clinical studies and for biomarker discovery. Substructures of glomeruli or the component of the glomerular filtration barrier, i.e. podocytes, mostly originating from the cell culture have also been investigated 65 .
Mesangial cells were also investigated, either from rat 66 , or human 67 . Many proteomic investigations focused on nephron physiology in cell culture models or brush-border membrane (BBM) vesicles 29 . There are attempts to analyze the membrane proteome of polarized epithelial cells and to provide a data set of the most abundant proteins present in renal proximal tubule cell membranes. Besides the study of Cutillas et al. 29 (discussed above), there is another report on the analysis of basolateral vs apical membrane in the rat IMCDs 31 .
In that study, biotinylation and streptavidin affinity chromatography were used to label and enrich proteins from apical and basolateral membranes of rat kidney inner medullary collecting ducts (IMCDs) prior to LC-MS/MS. That study identified 222 integral and GPIlinked membrane proteins.
In addition to whole cells and cell membranes, different organelles were also subject to proteomics analysis, like the mouse kidney peroxisomes. Except IMCD and glomeruli, to our knowledge no other isolated nephron segment was so far analyzed on the proteome level. However, global and segment-specific gene expression in the nephron has been addressed at the transcriptome level. Chabardes-Garonne et al.
isolated the glomerulus and seven different nephron segments by microdissection from human kidney and characterized their transcriptome using the serial analysis of gene expression (SAGE), resulting in data for the segment specific expression of more than 600 genes 2 . Given the recent developments in the field in mass spectrometry proteomics, global and segmentspecific studies of gene expression at the proteome level are within reach.
Structure-specific proteomics in other tissues
The kidney is not the only complex organ of which isolated substructures have been analyzed. Other examples are intestine, brain and pancreas. The colon epithelium is protected from the luminal microbes by an inner firmly attached mucus layer and an outer loose mucus layer, which were analyzed to better understand their protein composition 69 . Analyses were also performed on subcellular structures allowing detailed proteome analysis and corresponding functional characteristics of a specific organelle. Wong et al. studied microsomal organelles including the ER, Golgi, and prechylomicron transport vesicle (PCTV) 70 . Microsomes from primary hepatocytes and enterocytes from rodent liver and intestinal tissue were analyzed, and profiled with a combination of two-dimensional gel electrophoresis and mass spectrometry.
In the pancreas, Waanders et al 38 performed quantitative proteomic analysis of a single microdissected pancreatic islets and kidney glomeruli isolated by laser capture, demonstrating the sensitivity of state-of-the-art methods, and reported a list of a 7014 pancreatic islets proteins. Investigations have also been done toward a better understanding of beta-cells and 15 insulinoma cells in different conditions, in order to elucidate the mechanisms regulating insulin secretion and the development of various forms of diabetes, as well as to identify drug targets for therapeutic approaches 71 . As summarized in a recent review by Brunner et al 72 , there are several proteomic studies on effects of glucotoxicity in pancreas, pancreatic islets and β-cells. In addition, Farina et al 73 reported on a proteomic analysis of a human bile and its potential application for cancer diagnosis.
The brain is another complex organ requiring investigation on a substructure level.
Proteomics studies range from those where a proteome of an organelle is analyzed in different brain regions with a pharmacological aspect 74 , to those comparing human and animal (mouse) material 75 . Investigations of isolated brain regions are applied to diseases like schizophrenia,
Parkinson's disease, epilepsy, and bipolar disorder which have been associated with the thalamus 76 . Also in neurophysiology and neuropathology, studies are being performed in which specific subcellular compartments are investigated, resulting in e.g. mapping of the mouse brain cytosolic phosphoproteome 77 . Given its central importance, brain proteomics is a subject of intense research of scientific consortia, such as the Human Proteome Organization (HUPO) Brain Proteome Project 78 .
Application of proteomics to normal and diseased kidney function
Proteomics technology has been applied to study different aspects of normal kidney function, kidney function in genetically modified animals as well as disease processes in humans and various animal models of kidney diseases. The majority of studies focused on searching for markers of disease either in blood/serum or in urine. The obvious advantage of this approach is the simple and non-invasive access to these body fluids and the promise to uncover markers of early disease, its progression, prognosis, and the success of treatment.
This field of biomarker research has rapidly grown with the technical advancements. Adachi et al. have used high accuracy MS to detect more than 1500 proteins in human urine, 16 including a large proportion of membrane proteins, making urine indeed an interesting body fluid for biomarker research 79 . Similarly, Knepper and colleagues detected nearly 1100 proteins in human urinary exosomes and also determined phosphorylation sites 80 . Major achievements of urine proteomics have been reviewed elsewhere 3, 4, 81 . Clearly, major limitations in this field are that potential markers still require validation and that panels of markers rather than single markers may be needed for diagnosis and monitoring of disease progression. Unfortunately, little progress has been made in using urine proteomics to identify physiological or pathophysiological processes underlying disease development and progression. The problem here is that it is often unknown from where along the nephron certain proteins originate and if and how their appearance in urine correlates with their abundance and involvement in cellular processes.
Using kidney tissue, the most detailed studies using proteomics to examine physiological processes focused on the mechanisms of regulated water absorption and urine concentration along the inner medullary collecting duct (reviewed in: Hoffert et al. 57 ; Hoorn et al. 82 ;
Pisitkun et al. 83 ). These studies identified various novel proteins involved in the regulation of the AQP2 water channel and detected phosphoproteins and phosphorylation sites in the channel and associated proteins. Furthermore, transcription factors were discovered that may play a role in the cell-specific expression of AQP2 84 . Importantly, these studies were carried out with relatively pure starting material from the isolated and enriched inner medullary collecting duct allowing predicting regulatory pathways. Moreover, many of these studies
were not limited to the descriptive listing of proteins but tested also the functional relevance of some predicted pathways and phosphorylation sites.
Only few other studies went through the process of purifiying specific cells or nephron segments for the subsequent proteomic analysis 24, 62, [85] [86] [87] 88 . Most studies have applied proteomics to study disease processes using whole kidney tissue as material 55, [89] [90] [91] [92] [93] [94] . Obviously, this approach is simple and fast but has major limitations due to the morphological diversity and complexity of the kidney. Thus, using whole kidney material it appears impossible to deduce pathways since it remains unknown which cells expressed the proteins of interest and if several regulated proteins occurred in the same cells. It may therefore not come as a surprise that this approach has not yielded many more insights into fundamental (patho)physiological processes.
Outlook
At least fourmajor challenges for proteomics in the field of kidney research remain: 1) further refinement of tools, 2) integration of data from various levels of "-omics" A second challenge comes from the necessity to integrate data from different levels of "-omics" measurements such as transcriptome (miRNA, mRNA), proteome, phosphoproteome, or metabolome experiments. This type of analysis creates sets of data of enormous complexity and ambiguity. Proteins and metabolites are often linked to more than one pathway or are even not known yet to take part in specific pathways. With the ability to screen more and more posttranslational protein modifications, the complexity will even further increase.
Again, the purity and homogeneity of the starting material will be crucial to perform meaningful pathway analyses.
Inevitably, a third and fourth challenge arises from the complexity and ambiguity of data sets coming from such multi-layered experiments. In most cases, proteome measurements have represented the end-point of experiments. With the refinement of preparing the starting samples and more sensitive measurements it will be possible to better predict regulated pathways and functions. However, ultimately, these predictions will require functional and experimental proof returning to the paradigm of hypothesis-driven research. The importance and difficulty of these last two points must not be underestimated, but it will ultimately bring sense to the data generated by high-throughput screening methodologies.
Taken together proteomics of the nephron subsegments or ther specific kidney cell types, as well as the proteomics of urine, will in future provide a high throughput method in renal physiology and pathophysiology. This approach will also be used to elucidate proteinsignaling events, identifying the proteins involved as well as the modifications of these proteins. Together with functional experiments, this will lead towards a better understanding of renal diseases and the discovery of biomarkers that will improve diagnosis and treatment of renal diseases. 
